TY - JOUR
T1 - The causes of stillbirths in south Asia
T2 - results from a prospective study in India and Pakistan (PURPOSe)
AU - PURPOSe Study Group
AU - McClure, Elizabeth M.
AU - Saleem, Sarah
AU - Goudar, Shivaprasad S.
AU - Tikmani, Shiyam Sunder
AU - Dhaded, Sangappa M.
AU - Hwang, Kay
AU - Guruprasad, Gowdar
AU - Shobha, Dhananjaya
AU - Sarvamangala, B.
AU - Yogeshkumar, S.
AU - Somannavar, Manjunath S.
AU - Roujani, Sana
AU - Reza, Sayyeda
AU - Raza, Jamal
AU - Yasmin, Haleema
AU - Aceituno, Anna
AU - Parlberg, Lindsay
AU - Kim, Jean
AU - Bann, Carla M.
AU - Silver, Robert M.
AU - Goldenberg, Robert L.
AU - Goudar, Shivaprasad
AU - Nagmoti, Mahantesh B.
AU - Aradhya, Gayathri H.
AU - Nadig, Naveen
AU - Kusgur, Varun
AU - Raghoji, Chaitali R.
AU - Prakash, Veena
AU - Joish, Upendra Kumar
AU - Mangala, G. K.
AU - Rajashekhar, K. S.
AU - Kumar, Sunil
AU - Kulkarni, Vardendra
AU - Zafar, Afia
AU - Ahmed, Imran
AU - Uddin, Zeeshan
AU - Ghanchi, Najia
AU - Ariff, Shabina
AU - Sheikh, Lumaan
AU - Mirza, Waseem
AU - Prakash, Jai
AU - Haider, Furqan
AU - Moore, Janet L.
AU - Parepelli, Suchita
AU - Bann, Carla
AU - McClure, Elizabeth
AU - Goldenberg, Robert
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2022/7
Y1 - 2022/7
N2 - Background: South Asia contributes more than a third of all global stillbirths, yet the causes remain largely unstudied in this region. New investigations, including novel assessments of placental and fetal tissues, facilitate more precise determination of the underlying causes of stillbirth. We sought to assess underlying and contributing causes of stillbirth from settings in India and Pakistan. Methods: In this prospective cohort study (PURPOSe), we report the cause of death in stillbirths in hospitals in central India and south Pakistan (Davangere, India [three public and private hospitals] and Karachi, Pakistan [one public maternity and one children's hospital]). Women aged 15 years or older and with a known stillbirth (defined as a pregnancy at 20 or more weeks of gestation with the in-utero death of a fetus) weighing 1000 g or more were included in the study. Maternal clinical factors, placental evaluation, fetal tissue evaluation (from minimally invasive tissue sampling), and PCR for microbial pathogens were used to identify the causes of death. An expert panel reviewed available data for all stillbirths to identify the primary and contributing maternal, placental, and fetal causes of stillbirth. Findings: Between Sept 1, 2018, and Feb 12, 2020, 981 stillborns were included and, of those, 611 were reviewed by the expert panel. The primary maternal causes of stillbirth were hypertensive disease in 221 (36%) of 611 stillbirths, followed by severe anaemia in 66 (11%) stillbirths. The primary placental causes were maternal and fetal vascular malperfusion, in 289 (47%) stillbirths. The primary fetal cause of stillbirth was intrauterine hypoxia, in 437 (72%) stillbirths. We assessed the overlap of main causes and 116 (19%) stillbirths had intrauterine hypoxia, placental malperfusion, and eclampsia or pre-eclampsia indicated as primary causes of death. Infection (including of the placenta, its membranes, and in the fetus) and congenital anomalies also were causative of stillbirth. Interpretation: In south Asia, fetal asphyxia is the major cause of stillbirth. Several placental lesions, especially those associated with maternal and fetal vascular malperfusion and placental abruption, have an important role in asphyxia and fetal death. Maternal hypertension, and especially pre-eclampsia, is often the primary maternal condition associated with this pathway. Funding: Bill & Melinda Gates Foundation.
AB - Background: South Asia contributes more than a third of all global stillbirths, yet the causes remain largely unstudied in this region. New investigations, including novel assessments of placental and fetal tissues, facilitate more precise determination of the underlying causes of stillbirth. We sought to assess underlying and contributing causes of stillbirth from settings in India and Pakistan. Methods: In this prospective cohort study (PURPOSe), we report the cause of death in stillbirths in hospitals in central India and south Pakistan (Davangere, India [three public and private hospitals] and Karachi, Pakistan [one public maternity and one children's hospital]). Women aged 15 years or older and with a known stillbirth (defined as a pregnancy at 20 or more weeks of gestation with the in-utero death of a fetus) weighing 1000 g or more were included in the study. Maternal clinical factors, placental evaluation, fetal tissue evaluation (from minimally invasive tissue sampling), and PCR for microbial pathogens were used to identify the causes of death. An expert panel reviewed available data for all stillbirths to identify the primary and contributing maternal, placental, and fetal causes of stillbirth. Findings: Between Sept 1, 2018, and Feb 12, 2020, 981 stillborns were included and, of those, 611 were reviewed by the expert panel. The primary maternal causes of stillbirth were hypertensive disease in 221 (36%) of 611 stillbirths, followed by severe anaemia in 66 (11%) stillbirths. The primary placental causes were maternal and fetal vascular malperfusion, in 289 (47%) stillbirths. The primary fetal cause of stillbirth was intrauterine hypoxia, in 437 (72%) stillbirths. We assessed the overlap of main causes and 116 (19%) stillbirths had intrauterine hypoxia, placental malperfusion, and eclampsia or pre-eclampsia indicated as primary causes of death. Infection (including of the placenta, its membranes, and in the fetus) and congenital anomalies also were causative of stillbirth. Interpretation: In south Asia, fetal asphyxia is the major cause of stillbirth. Several placental lesions, especially those associated with maternal and fetal vascular malperfusion and placental abruption, have an important role in asphyxia and fetal death. Maternal hypertension, and especially pre-eclampsia, is often the primary maternal condition associated with this pathway. Funding: Bill & Melinda Gates Foundation.
UR - http://www.scopus.com/inward/record.url?scp=85131956556&partnerID=8YFLogxK
U2 - 10.1016/S2214-109X(22)00180-2
DO - 10.1016/S2214-109X(22)00180-2
M3 - Article
C2 - 35714647
AN - SCOPUS:85131956556
SN - 2214-109X
VL - 10
SP - e970-e977
JO - The Lancet Global Health
JF - The Lancet Global Health
IS - 7
ER -